Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/IIa Trial of Folate Binding Protein (FBP) Peptide (E39) Vaccine in Ovarian and Endometrial Cancer Patients

NCT01580696 is registered in ClinicalTrials.gov with COL George Peoples, MD, FACS as lead sponsor.

NCT NCT01580696
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01580696 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/IIa Trial of Folate Binding Protein (FBP) Peptide (E39) Vaccine in Ovarian and Endometrial Cancer Patients
Lead sponsor
COL George Peoples, MD, FACS
Phase
Phase 1/2
Overall status
Completed
Start date
April 30, 2012
Completion date
July 31, 2016
Enrollment
51 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer, fallopian cancer, ovarian cancer, peritoneal cancer